AVXL Financials
Anavex Life Sciences Corp - Financial statements & key metrics
Stock Price
$2.87
Market Cap
$247.43M
P/E Ratio
-5.3
EPS
$-0.54
Income Statement Highlights
Most Recent Quarter: 2025-09-30
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-46.38M
EPS (Diluted)
$-0.54
Balance Sheet Highlights
Total Assets
$103.81M
Total Liabilities
$8.95M
Shareholders Equity
-
Cash & Equivalents
$102.58M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-39.04M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-43.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AVXL revenue?
View AVXL's income statement for detailed revenue data.
Is AVXL profitable?
AVXL reported a loss of $46.38M in the most recent quarter.
What is AVXL market cap?
AVXL has a market capitalization of $247.43M, making it a small-cap stock.
Does AVXL have debt?
View AVXL's balance sheet for debt information.
What is AVXL cash flow?
Cash flow data is available in the full financial statements.